July 31, 2024
With a record number of health sector winners this year, the WIPO Global Awards underscore the growing importance of small enterprises and startups in driving impactful healthcare solutions worldwide by recognizing and supporting innovators who leverage IP-backed strategies.
The World Intellectual Property Organization (WIPO) on held the third edition of the WIPO Global Awards, on 12 July 2024 spotlighting pioneering Small- and Medium-sized Enterprises (SMEs) and startups that leverage intellectual property (IP) for business success and social impact. This year, health technologies dominated the stage, with six of the nine winners focusing on the health sector. These winners were selected to be the best from a record 660+ applications this year from 107 countries.
The WIPO Global Awards invite small businesses from around the world to present their innovations, offering winners tailored mentoring on IP commercialization, international promotion, networking opportunities in Geneva, as well as access to WIPO’s resources and advisory network.
The selection process for the awards focuses on strong IP management practices, which includes strategies for acquiring, protecting, and utilizing IP rights. Companies are also evaluated on their IP awareness and how their innovations contribute to sustainable development goals (SDGs). This ensures that grass roots innovators are not only IP savvy but are also dedicated to using IP in their strategy for commercial success, driving positive development outcomes.
Applications from the health sector have been growing. This year alone, we received about 150 applications from medical innovators with a registered company and a clear IP strategy to drive their business. The prominence of health technology firms among the award entries and winners across all three editions underscores a strong emphasis on healthcare innovation within the SME and startup community. It also highlights the pressing global need for such solutions and the potential to transfer them to countries with demand for such solutions, with WIPO’s guidance enhancing these efforts.
This year’s winners from the health sector presented remarkable innovations, showcasing creativity and impact.
These winners, representing developing countries across various regions, address a wide range of healthcare needs, including assistive care, diagnostics, surgical care, and the treatment of non-communicable diseases. Their innovations demonstrate how effective IP strategies can drive the development of portable, easy-to-deploy healthcare technologies, thereby enhancing access to healthcare and medical solutions.
A representative of Healinno Tech, one of the winners of the 2024 WIPO Global Awards, at a ceremony held during the July 9-17 Assemblies of WIPO Member States.
Past winners from the health sector have utilized the awards to strengthen their IP strategies and scale their innovations. For instance, Centro de Retina Medica y Quirúrigca (CRMQ), a Mexican company developing a nanotech retinal drug delivery system that won in 2023, plans to leverage its IP portfolio to build an international distribution network. Lucence Lifesciences, a 2022 winner from Singapore, raised $46 million post-award and has recently launched in the United States market. Raycan from China, another 2022 winner, expanded its IP portfolio through the Madrid System, which the company credits for laying the foundation for international growth. This year’s winners are also expected to utilize the Awards and associated WIPO services to expand their business and contribute to the advancement of healthcare systems.
In a round table discussion that followed the WIPO Global Awards ceremony, Phillipe Dewost, Member of the Jury for the Awards this year, emphasized the importance of initiatives that promote technologies addressing global health and environmental challenges. Marcelo Di Pietro Peralta, Director, WIPO Global Awards, hopes the winners will serve as “ambassadors” for IP systems and relevant administrative offices in their country, encouraging governments to enhance their sophistication and go beyond merely providing IP rights.
Emphasizing the importance of IP in business and commercialization efforts, the WIPO Global Awards serves as a model for medical innovators on how to identify key obstacles in innovations and drive improvements globally.
With a record number of health sector winners this year, the WIPO Global Awards underscore the growing importance of SMEs and startups in driving impactful healthcare solutions worldwide by recognizing and supporting innovators who leverage IP-backed strategies.
The success stories of past winners and the commitments made by this year’s cohort demonstrate WIPO’s commitment to nurturing and accelerating healthcare innovation, ultimately contributing to improved global health outcomes.